Regulation of in vitro diagnostics (IVDs) for use in Australian pathology laboratories: A gloomy outlook for future pathology testing in this country?

Pathology

Volumn 43, Issue 4, 2011, Pages 397-402

  Favaloro, Emmanuel J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052200298     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283468c70     Document Type: Letter

References (14)

1. Australian Government, Department of Health and Ageing, Therapeutic Goods Administration (TGA). Overview of the New Regulatory Framework for in vitro diagnostic medical devices (IVDs). February, 2009. Available from the TGA website: http://www.tga.gov.au
2. Cohen P. The changing regulatory environment of in vitro diagnostics: implications for sponsors, manufacturers and laboratory users. Aus J Med Sci 2010; 31: 9-15.
3. Favaloro EJ. Harmonising quality to the lowest clinical diagnostic standard? The case against regulation of in vitro diagnostics (IVDs) for us in clinical diagnostic laboratories. Aust J Med Sci 2010; 31: 56-64.
4. Therapeutic Goods Administration (TGA). IVD Pricing Schedule (from 1 July 2010). http://www.tga.gov.au/ivd/fees.htm
5. Therapeutic Goods Administration (TGA). Guidance for IVD Sponsors - A Roadmap to Market. http://www.tga.gov.au/devices/ivd-overview.htm
6. Favaloro EJ, McVicker W, Hamdam S, Hocker N. Improving the harmonization of the International Normalized Ratio (INR): Time to think outside the box? Clin Chem Lab Med 2010; 48: 1079-90.
7. Favaloro EJ. Standardisation, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits and limitations. Semin Thromb Hemostas 2007; 33: 290-7. (Pubitemid 46581384)
8. Bonar R, Favaloro EJ, Adcock D. Quality in coagulation and haemostasis testing. Biochemia Medica 2010; 20: 184-99.
9. Lippi G, Plebani M, Favaloro EJ, Trenti T. Laboratory testing in pharmacies. Clin Chem Lab Med 2010; 48: 943-53.
10. Lippi G, Plebani M. The 'Obamanomics': a revolution in laboratory diagnostics. Clin Chem Lab Med 2010; 48: 741-3.
11. Favaloro EJ. Towards a new paradigm for the identification and functional characterisation of von Willebrand disease. Semin Thromb Hemost 2009; 35: 60-75.
12. Favaloro EJ, Wong RCW. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: Findings from the 2008 Australasian antiphospholipid antibody survey. Pathology 2009; 41: 666-75.
13. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7: 1737-40.
14. Favaloro EJ. Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease. Thromb Haemost 2010; 104: 1009-21.